Protagonist Therapeutics, Inc. (PTGX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 25.70 |
| Open | 25.13 |
| Bid | 24.62 x 200 |
| Ask | 24.69 x 200 |
| Day's Range | 24.52 - 25.14 |
| 52 Week Range | 13.72 - 33.34 |
| Volume | |
| Avg. Volume | 665,940 |
| Market Cap | 1.437B |
| Beta (5Y Monthly) | 2.05 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
All You Need to Know About Protagonist Therapeutics (PTGX) Rating Upgrade to Buy
Protagonist Therapeutics (PTGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- GuruFocus.com
Protagonist Therapeutics Inc CEO Sells 25,000 Shares
Protagonist Therapeutics Inc (NASDAQ:PTGX), a biopharmaceutical company, has reported an insider sale according to a recent SEC filing.
- Simply Wall St.
Shareholders have faith in loss-making Protagonist Therapeutics (NASDAQ:PTGX) as stock climbs 3.7% in past week, taking five-year gain to 135%
Protagonist Therapeutics, Inc. ( NASDAQ:PTGX ) shareholders might be concerned after seeing the share price drop 10% in...
© 2024 Yahoo. All rights reserved.